XOMA
XOMA Corp
Price:  
29.35 
USD
Volume:  
33,052.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XOMA EV/EBITDA

-184.4%
Upside

As of 2024-12-12, the EV/EBITDA ratio of XOMA Corp (XOMA) is -16.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XOMA's latest enterprise value is 321.61 mil USD. XOMA's TTM EBITDA according to its financial statements is -19.87 mil USD. Dividing these 2 quantities gives us the above XOMA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.7x - 17.4x 16.0x
Forward P/E multiples 15.7x - 21.4x 15.8x
Fair Price (24.51) - (27.27) (24.78)
Upside -183.5% - -192.9% -184.4%
29.35 USD
Stock Price
(24.78) USD
Fair Price

XOMA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-29 -18.61
2024-11-27 -18.45
2024-11-26 -18.87
2024-11-25 -17.17
2024-11-22 -16.69
2024-11-21 -16.61
2024-11-20 -16.58
2024-11-19 -16.63
2024-11-18 -16.57
2024-11-15 -16.69
2024-11-14 -16.50
2024-11-13 -16.39
2024-11-12 -17.31
2024-11-11 -17.25
2024-11-08 -17.14
2024-11-07 -16.69
2024-11-06 -18.02
2024-11-05 -17.17
2024-11-04 -17.08
2024-11-01 -16.79
2024-10-31 -16.69
2024-10-30 -16.48
2024-10-29 -17.71
2024-10-28 -16.70
2024-10-25 -16.28
2024-10-24 -16.27
2024-10-23 -16.05
2024-10-22 -15.77
2024-10-21 -15.65
2024-10-18 -16.21
2024-10-17 -15.88
2024-10-16 -16.26
2024-10-15 -15.80
2024-10-14 -15.52
2024-10-11 -15.14
2024-10-10 -14.68
2024-10-09 -14.97
2024-10-08 -15.06
2024-10-07 -15.03
2024-10-04 -15.17
2024-10-03 -14.43
2024-10-02 -15.01
2024-10-01 -14.87
2024-09-30 -14.48
2024-09-27 -14.20
2024-09-26 -13.89
2024-09-25 -14.26
2024-09-24 -14.74
2024-09-23 -14.84
2024-09-20 -15.49